Furthermore, encouraging data show that increased neurogranin fragments in CSF correlate with future cognitive decline, brain atrophy, and glucose metabolism, even at early stages of the disease [117, 119–121], and that the increase in CSF neurogranin seems to be specific for AD [122, 123]. The gene discussed is NRGN; the disease is Brain atrophy.